CaaMTech Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$22M
- Investors
-
3
CaaMTech General Information
Description
Developer of medicine discovery and optimization technology designed to focus on engineering psychedelic drugs.The company utilizes a collaborative scientific approach to engineer novel small-molecule therapeutics, focusing on the synthesis and crystallographic characterization of novel tryptamines, psilocin prodrugs, non-hallucinogenic neuroplastogens, synthetic psychedelic formulations, and chemical standards, enabling pharmaceutical researchers to access optimized compounds for antidepressant-associated neuroplasticity.
Contact Information
Website
www.caam.techCorporate Office
- 58 East Sunset Way
- Unit 209
- Issaquah, WA 98027
- United States
Corporate Office
- 58 East Sunset Way
- Unit 209
- Issaquah, WA 98027
- United States
CaaMTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 08-Sep-2021 | $22M | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 01-Jan-2019 | Completed | Startup |
CaaMTech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
CaaMTech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CaaMTech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CaaMTech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kortschak Investments | Venture Capital | Minority | ||
| Noetic Fund | Venture Capital | Minority | ||
| Mont Alto Capital | Family Office | Minority |
CaaMTech FAQs
-
When was CaaMTech founded?
CaaMTech was founded in 2019.
-
Where is CaaMTech headquartered?
CaaMTech is headquartered in Issaquah, WA.
-
What is the size of CaaMTech?
CaaMTech has 9 total employees.
-
What industry is CaaMTech in?
CaaMTech’s primary industry is Drug Discovery.
-
Is CaaMTech a private or public company?
CaaMTech is a Private company.
-
What is the current valuation of CaaMTech?
The current valuation of CaaMTech is .
-
What is CaaMTech’s current revenue?
The current revenue for CaaMTech is .
-
How much funding has CaaMTech raised over time?
CaaMTech has raised $23.3M.
-
Who are CaaMTech’s investors?
Kortschak Investments, Noetic Fund, and Mont Alto Capital have invested in CaaMTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
